Influence of the surfactant concentration on the body distribution of nanoparticles

Journal of Drug Targeting

Volumn 6, Issue 5, 1999, Pages 373-385

  Araujo, L ^a   Lobenberg R ^a   Kreuter, J ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Body distribution; Drug targeting; Nanoparticles; Poly(methyl methacrylate); Surfactant coating

Indexed keywords

CARBON 14; NANOPARTICLE; NONIONIC SURFACTANT; POLOXAMINE 908; POLY(METHYL METHACRYLATE); POLYSORBATE 80; SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BODY DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETICULOENDOTHELIAL SYSTEM; TISSUE LEVEL;

EID: 0345280812     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869908996844     Document Type: Article

References (25)

1. Bazile, D., Prud'Homme, C., Bassoullet, M.T., Marlard, M., Spenlenhauer, G. and Veillard, M. (1995) Stealth Me. PEG-PLA nanoparticles avoid uptake by the mononuclear phagocyte system. J. Pharm. Sciences, 84, 493-498.
2. Blunk, T., Hochstrasser, D.F. Sanchez, J.-C., Müller, B.W. and Müller, R.H. (1993) Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis, 14, 1382-1387.
3. Blunk, T., Lück, M., Calvör, A., Hochstrasser, D.F., Sanchez, J.C., Müller, B.W. and Müller, R.H. (1996) Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting. Eur. J. Pharm., Biopharm., 42, 262-268.
4. Borchard, G. and Kreuter, J. (1993) Interaction of serum components with poly(methyl methacrylate) nanoparticles and the resulting body distribution after intravenous injection in rats. J. Drug Target., 1, 15-19.
5. Borchard, G. and Kreuter, J. (1996) The role of serum complement on the organ distribution of intravenously administered poly(methyl methacrylate) nanoparticles: Effects of pre-coating with plasma and with serum complement. Pharm. Res., 13, 1055-1058.
6. Dunn, S.E., Coombes, A.G.A., Garnett, M.C., Davos, S.S., Davies, M.C. and Illum, L. (1997) In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers. J. Control. Rel., 44, 65-76.
7. Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchillin, V. and Langer, R. (1994) Biodegradable long-circulating polymeric nanospheres. Science, 23, 1600-1603.
8. Illum, L. and Davis, S.S. (1983) Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration. J. Pharm. Sci., 72, 1086-1089.
9. Illum, L. and Davis, S.S. (1984) The organ uptake of intravenously administered colloidal particles can be altered using a nonionic surfactant (poloxamer 338). FEBS Lett., 167, 79-82.
10. Illum, L., Hunneyball, I.M. and Davis, S.S. (1986) The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages. Int. J. Pharm., 29, 53-65.
11. Illum, L., Davis, S.S., Müller, R.H., Mak, E. and West, P. (1987) The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilised with a block-copolymer - poloxamine 908. Life Sci., 40, 367-374.
12. Kreuter, J. (1983) Evaluation of nanoparticles as Drug-delivery systems II. Comparison of the body distribution of nanoparticles with the body distribution of microspheres (diameter >1 μm), liposomes, and emulsion. Pharm. Acta Helv., 58, 217-250.
13. Kreuter, J. (1994) Nanoparticles, In J. Kreuter (ed.) Colloidal Drug Delivery Systems, New York: M. Dekker, pp. 219-342.
14. 60Co-γ-irradiation for the production of vaccines. Radiation Effects, 35, 161-166.
15. Lasic, D.D. (1994) Sterisch stabilisierte Vesikel. Angew. Chem., 106, 1765-1778.
16. Lasic, D.D. and Papahadjopoulos, D. (1995) Liposomes revisited. Science, 267, 1275-1276.
17. Moghimi, S.M., Muir, I.S., Illum, L., Davis, S.S. and Kolb-Bachofen, V. (1993) Coating particles with a block copolymer (poloxamine 908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochem. Biophys. Acta, 1179, 157-165.
18. Müller, R.H. and Wallis, K.H (1983) Surface modification of i.v. injectable biodegradable nanoparlicles with poloxamer polymers and poloxamine 908. Int. J. Pharm., 89, 25-31.
19. Müller, R.H. (1991) Colloidal Carriers for Controlled Drug Delivery and Targeting, Stuttgart Wiss. Verlag.
20. Müller, R.H., Wallis, K.H., Tröster, S.D. and Kreuter, J. (1992) In vitro characterisation of poly(methyl methacrylate) nanoparticles and correlation to their in vivo fate. J. Control. Rel., 20, 237-249.
21. Schroën, C.G.P.H., Cohen Stuart, M.A., van der Voort Maarschalk, K., van der Padt, A. and van't Riet, K. (1995) Influence of preadsorbed block copolymers on protein adsorption: Surface properties, layer thickness, and surface coverage. Langmuir, 11, 3068-3074.
22. Tröster, S.D., Müller, U. and Kreuter, J. (1990) Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants. Int. J. Pharm., 61, 85-100.
23. 14C-poly(methyl methacrylate) nanoparticles. J. Microencapsul., 9, 19-28.
24. 14C-poly (methylmethacrylate) nanoparticles to their body distribution. J. Control. Rel., 20, 247-260.
25. Wallis, K.H. and Müller, R.H. (1990) Stabilität von Poloxamer and Poloxamine Coating-Filmen auf Polystyrol Nanopartikeln. Acta Pharm. Technol., 36, 127-132.